OMB APPROVAL
                                                           OMB Number: 3235-0145
                                                      Expires: December 31, 2005
                                                        Estimated average burden
                                                     hours per response . . . 15


                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                  SCHEDULE 13D
                    Under the Securities Exchange Act of 1934
                            (Amendment No. ________)*


                                NMT Medical, Inc.

                                (Name of Issuer)

                                  Common Shares

                         (Title of Class of Securities)

                                    629294109

                                 (CUSIP Number)

                    Brian P. Bouda, Chief Compliance Officer
                            Federated Investors, Inc.
                            Federated Investors Tower
                            Pittsburgh, PA 15222-3779
                                  412-288-8634
           (Name, Address and Telephone Number of Person Authorized to
                       Receive Notices and Communications)

                               September 20, 2004

             (Date of Event which Requires Filing of this Statement)

If the filing person has previously  filed a statement on Schedule 13G to report
the  acquisition  that is the subject of this  Schedule  13D, and is filing this
schedule because of ss.ss.240.13d-1(e),  240.13d-1(f) or 240.13d-1(g), check the
following box. [X]

Note:  Schedules  filed in paper format shall include a signed original and five
copies of the  schedule,  including  all exhibits.  See  ss.240.13d-7  for other
parties to whom copies are to be sent.

*    The  remainder  of this  cover  page  shall be filled  out for a  reporting
     person's  initial  filing on this form with respect to the subject class of
     securities,  and for any subsequent amendment containing  information which
     would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).

Persons who respond to the collection of information  contained in this form are
not required to respond  unless the form displays a currently  valid OMB control
number.


SEC 1746 (11-03)



CUSIP No. 629294109

1.  Names of Reporting Persons.
    I.R.S. Identification Nos. of above persons (entities only).
        Federated Investors, Inc.

2.  Check the Appropriate Box if a Member of a Group (See Instructions)
    (a).
    (b)

3. SEC Use Only.

4. Source of Funds (See Instructions)  OO

5. Check if Disclosure of Legal Proceedings Is Required Pursuant to
   Items 2(d) or 2(e)

6. Citizenship or Place of Organization:  Pennsylvania

Number of               7. Sole Voting Power  1,114,200
Shares Bene-            8. Shared Voting Power
ficially by.            9. Sole Dispositive Power 1,114,200
Owned by Each           10.  Shared Dispositive Power
Reporting Person
With

11. Aggregate Amount Beneficially Owned by Each Reporting Person. 1,114,200

12. Check if the Aggregate Amount in Row (11) Excludes Certain
    Shares (See Instructions)

13. Percent of Class Represented by Amount in Row (11) 9.23%

14. Type of Reporting Person (See Instructions)  HC

1.  Names of Reporting Persons.
    I.R.S. Identification Nos. of above persons (entities only).
        Voting Shares Irrevocable Trust

2.  Check the Appropriate Box if a Member of a Group (See Instructions)
    (a).
    (b)

3. SEC Use Only.

4. Source of Funds (See Instructions) OO

5. Check if Disclosure of Legal Proceedings Is Required Pursuant to
   Items 2(d) or 2(e)

6. Citizenship or Place of Organization:  Pennsylvania

Number of               7.       Sole Voting Power  1,114,200
Shares Bene-            8.       Shared Voting Power
ficially by.            9.       Sole Dispositive Power 1,114,200
Owned by Each           10.      Shared Dispositive Power
Reporting Person
With

11. Aggregate Amount Beneficially Owned by Each Reporting Person 1,114,200

12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares
    (See Instructions)

13. Percent of Class Represented by Amount in Row (11)  9.23%

14. Type of Reporting Person (See Instructions)  OO

1.  Names of Reporting Persons.
    I.R.S. Identification Nos. of above persons (entities only).
        John F. Donahue.
------------------------------------------------------------------------------

2.  Check the Appropriate Box if a Member of a Group (See Instructions)
    (a).
    (b)

3. SEC Use Only.

4. Source of Funds (See Instructions) OO

5. Check if Disclosure of Legal Proceedings Is Required Pursuant to
   Items 2(d) or 2(e)

6. Citizenship or Place of Organization:  Pennsylvania

Number of               7. Sole Voting Power
Shares Bene-            8. Shared Voting Power 1,114,200
ficially by.            9.  Sole Dispositive Power
Owned by Each           10.  Shared Dispositive Power 1,114,200
Reporting Person
With

11. Aggregate Amount Beneficially Owned by Each Reporting Person 1,114,200

12. Check if the Aggregate Amount in Row (11) Excludes Certain
    Shares (See Instructions)

13. Percent of Class Represented by Amount in Row (11) 9.23%

14. Type of Reporting Person (See Instructions) IN

1.  Names of Reporting Persons.
    I.R.S. Identification Nos. of above persons (entities only).
        Rhodora J. Donahue
------------------------------------------------------------------------------

2.  Check the Appropriate Box if a Member of a Group (See Instructions)
    (a).
    (b)

3. SEC Use Only.

4. Source of Funds (See Instructions) OO

5. Check if Disclosure of Legal Proceedings Is Required Pursuant to
   Items 2(d) or 2(e)

6. Citizenship or Place of Organization:  Pennsylvania

Number of               7. Sole Voting Power
Shares Bene-            8. Shared Voting Power 1,114,200
ficially by.            9.  Sole Dispositive Power
Owned by Each           10.  Shared Dispositive Power 1,114,200
Reporting Person
With

11. Aggregate Amount Beneficially Owned by Each Reporting Person 1,114,200

12. Check if the Aggregate Amount in Row (11) Excludes Certain
    Shares (See Instructions)

13. Percent of Class Represented by Amount in Row (11) 9.23%

14. Type of Reporting Person (See Instructions) IN


1.  Names of Reporting Persons.
    I.R.S. Identification Nos. of above persons (entities only).
        J. Christopher Donahue.

2.  Check the Appropriate Box if a Member of a Group (See Instructions)
    (a).
    (b)

3. SEC Use Only.

4. Source of Funds (See Instructions) OO

5. Check if Disclosure of Legal Proceedings Is Required Pursuant to
   Items 2(d) or 2(e)

6. Citizenship or Place of Organization:  Pennsylvania

Number of               7. Sole Voting Power
Shares Bene-            8. Shared Voting Power 1,114,200
ficially by.            9.  Sole Dispositive Power
Owned by Each           10.  Shared Dispositive Power 1,114,200
Reporting Person
With

11. Aggregate Amount Beneficially Owned by Each Reporting Person. 1,114,200

12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares
    (See Instructions)

13. Percent of Class Represented by Amount in Row (11) 9.23%

14. Type of Reporting Person (See Instructions) IN

Instructions for Cover Page

(1) Names and I.R.S.  Identification Numbers of Reporting Persons -- Furnish the
full legal name of each person for whom the report is filed - i.e.,  each person
required to sign the schedule  itself - including each member of a group. Do not
include the name of a person  required to be identified in the report but who is
not a reporting  person.  Reporting persons that are entities are also requested
to furnish  their I.R.S.  identification  numbers,  although  disclosure of such
numbers is voluntary,  not mandatory  (see "SPECIAL  INSTRUCTIONS  FOR COMPLYING
WITH SCHEDULE 13D" below).

(2) If any of the shares  beneficially owned by a reporting person are held as a
member of a group and the  membership  is expressly  affirmed,  please check row
2(a). If the  reporting  person  disclaims  membership in a group or describes a
relationship  with other  persons but does not affirm the  existence of a group,
please check row 2(b) [unless it is a joint filing pursuant to Rule  13d-1(k)(1)
in which case it may not be necessary to check row 2(b)]

(3) The 3rd row is for SEC internal use; please leave blank.

(4)  Classify the source of funds or other  consideration  used or to be used in
making purchases as required to be disclosed  pursuant to Item 3 of Schedule 13D
and insert the appropriate  symbol (or symbols if more than one is necessary) in
row (4):

Category of Source Symbol
Subject Company (Company whose securities are being acquired) SC
Bank BK
Affiliate (of reporting person) AF
Working Capital (of reporting person) WC
Personal Funds (of reporting person) PF
Other OO

(5) If disclosure of legal proceedings or actions is required pursuant to either
Items 2(d) or 2(e) of Schedule 13D, row 5 should be checked.

(6)  Citizenship  or Place of  Organization  - Furnish  citizenship if the named
reporting person is a natural person. Otherwise,  furnish place of organization.
(See Item 2 of Schedule 13D.)

(7)-(11),  (13) Aggregate Amount  Beneficially  Owned by Each Reporting  Person,
etc.  -- Rows (7)  through  (11)  inclusive,  and (13)  are to be  completed  in
accordance with the provisions of Item 5 of Schedule 13D. All percentages are to
be rounded off to nearest tenth (one place after decimal point).

(12) Check if the aggregate  amount reported as  beneficially  owned in row (11)
does not include shares which the reporting  person  discloses in the report but
as to which  beneficial  ownership is disclaimed  pursuant to Rule 13d-4 [17 CFR
240.13d-4] under the Securities Exchange Act of 1934.

(14) Type of  Reporting  Person  --  Please  classify  each  "reporting  person"
according  to the  following  breakdown  and place the  appropriate  symbol  (or
symbols, i.e., if more than one is applicable, insert all applicable symbols) on
the form:

Category Symbol
Broker-Dealer BD
Bank BK
Insurance Company IC
Investment Company IV
Investment Adviser IA
Employee Benefit Plan or Endowment Fund EP
Parent Holding Company/Control Person HC
Savings Association SA
Church Plan CP
Corporation CO
Partnership PN
Individual IN
Other OO

Notes:

Attach as many copies of the second  part of the cover page as are  needed,  one
reporting person per page.

Filing persons may, in order to avoid unnecessary  duplication,  answer items on
the schedules (Schedule 13D, 13G or 14D-1) by appropriate cross references to an
item or items on the cover  page(s).  This  approach  may only be used where the
cover page item or items  provide all the  disclosure  required by the  schedule
item. Moreover, such a use of a cover page item will result in the item becoming
a part of the schedule and accordingly  being considered as "filed" for purposes
of  Section  18 of the  Securities  Exchange  Act or  otherwise  subject  to the
liabilities of that section of the Act.

Reporting persons may comply with their cover page filing requirements by filing
either  completed  copies  of the blank  forms  available  from the  Commission,
printed or typed  facsimiles,  or  computer  printed  facsimiles,  provided  the
documents  filed  have  identical   formats  to  the  forms  prescribed  in  the
Commission's  regulations and meet existing  Securities Exchange Act rules as to
such matters as clarity and size (Securities Exchange Act Rule 12b-12).

              SPECIAL INSTRUCTIONS FOR COMPLYING WITH SCHEDULE 13D

     Under Sections 13(d) and 23 of the Securities  Exchange Act of 1934 and the
rules and  regulations  thereunder,  the Commission is authorized to solicit the
information required to be supplied by this schedule by certain security holders
of certain issuers.

     Disclosure  of the  information  specified in this  schedule is  mandatory,
except for I.R.S.  identification numbers, disclosure of which is voluntary. The
information  will be used for the primary  purpose of determining and disclosing
the holdings of certain  beneficial  owners of certain equity  securities.  This
statement will be made a matter of public  record.  Therefore,  any  information
given will be available for inspection by any member of the public.

     Because of the public nature of the information, the Commission can utilize
it  for  a  variety  of  purposes,  including  referral  to  other  governmental
authorities  or  securities  self-regulatory   organizations  for  investigatory
purposes or in connection with litigation  involving the Federal securities laws
or  other  civil,   criminal  or  regulatory  statutes  or  provisions.   I.R.S.
identification numbers, if furnished,  will assist the Commission in identifying
security holders and, therefore, in promptly processing statements of beneficial
ownership of securities.

     Failure to disclose the information requested by this schedule,  except for
I.R.S.  identification  numbers,  may result in civil or criminal action against
the persons  involved  for  violation of the Federal  securities  laws and rules
promulgated thereunder.

                              General Instructions

A. The item  numbers and captions of the items shall be included but the text of
the items is to be omitted.  The answers to the items shall be so prepared as to
indicate clearly the coverage of the items without  referring to the text of the
items.  Answer every item.  If an item is  inapplicable  or the answer is in the
negative, so state.

B.  Information  contained in exhibits to the statements may be  incorporated by
reference in answer or partial  answer to any item or sub-item of the  statement
unless it would render such answer misleading, incomplete, unclear or confusing.
Material  incorporated by reference shall be clearly identified in the reference
by  page,  paragraph,  caption  or  otherwise.  An  express  statement  that the
specified  matter is  incorporated  by reference shall be made at the particular
place  in the  statement  where  the  information  is  required.  A copy  of any
information  or a copy of the  pertinent  pages of a  document  containing  such
information  which is  incorporated  by reference  shall be submitted  with this
statement as an exhibit and shall be deemed to be filed with the  Commission for
all purposes of the Act.

C. If the statement is filed by a general or limited partnership,  syndicate, or
other group, the information called for by Items 2-6, inclusive,  shall be given
with respect to (i) each partner of such general partnership;  (ii) each partner
who is denominated as a general partner or who functions as a general partner of
such limited partnership; (iii) each member of such syndicate or group; and (iv)
each person  controlling such partner or member.  If the statement is filed by a
corporation  or if a  person  referred  to in (i),  (ii),  (iii) or (iv) of this
Instruction is a corporation,  the information called for by the above mentioned
items shall be given with respect to (a) each executive  officer and director of
such corporation;  (b) each person  controlling such  corporation;  and (c) each
executive  officer and director of any corporation or other person ultimately in
control of such corporation.

Item 1. Security and Issuer

        NMT Medical, Inc.
        27 Wormword Street, Boston, MA 02210

Item 2. Identity and Background

(a) See Row 1 of Cover Pages

(b) Federated Investors Tower, Pittsburgh, PA 15222-3779

(c) Not applicable

(d) Not applicable

(e) Not applicable

(f) See Row 6 of Cover Pages

Item 3. Source and Amount of Funds or Other Consideration

     Shares of the issuer were purchased in the amount of $6,852,722 with assets
of the Federated  Kaufmann Fund, a portfolio of Federated  Equity Funds,  and in
the amount of $21,512 with assets of the Federated Kaufmann Fund II, a portfolio
of Federated Insurance Series.

Item 4. Purpose of Transaction

     The shares of the issuer were  originally  acquired for  investment  in the
ordinary  course of  business  and not with the  purpose  nor with the effect of
changing or influencing  the control of the issuer.  A Schedule 13G with respect
to such acquisition has been previously filed. On September 20, 2004, the filing
person  of this  Schedule  13D  communicated  with the  issuer  and its board of
directors  indicating the filing  person's desire that the issuer explore a sale
or other disposition of the company.

Item 5. Interest in Securities of the Issuer

(a)   Federated Investors, Inc.
      Amount beneficially owned: 1,114,200 - 9.23%
(b)   Sole power to vote or to direct the vote 1,114,200
      Shared power to vote or to direct the vote -0-
      Sole power to dispose or to direct the disposition 1,114,200
      Shared power to dispose or to direct the disposition -0-
(c)   Not applicable
(d)   Not applicable
(e)   Not applicable

(a)   Voting Shares Irrevocable Trust
      Amount beneficially owned: 1,114,200 - 9.23%
(b)   Sole power to vote or to direct the vote 1,114,200
      Shared power to vote or to direct the vote -0-
      Sole power to dispose or to direct the disposition 1,114,200
      Shared power to dispose or to direct the disposition -0-
(c)   Not applicable
(d)   Not applicable
(e)   Not applicable

(a)   John F. Donahue
      Amount beneficially owned: 1,114,200 - 9.23%
(b)   Sole power to vote or to direct the vote -0-
      Shared power to vote or to direct the vote 1,114,200
      Sole power to dispose or to direct the disposition -0-
      Shared power to dispose or to direct the disposition 1,114,200
(c)   Not applicable
(d)   Not applicable
(e)   Not applicable

(a)   Rhodora J. Donahue
      Amount beneficially owned: 1,114,200 - 9.23%
(b)   Sole power to vote or to direct the vote -0-
      Shared power to vote or to direct the vote 1,114,200
      Sole power to dispose or to direct the disposition -0-
      Shared power to dispose or to direct the disposition 1,114,200
(c)   Not applicable
(d)   Not applicable
(e)   Not applicable

(a)   J. Christopher Donahue
      Amount beneficially owned: 1,114,200 - 9.23%
(b)   Sole power to vote or to direct the vote -0-
      Shared power to vote or to direct the vote 1,114,200
      Sole power to dispose or to direct the disposition -0-
      Shared power to dispose or to direct the disposition 1,114,200
(c)   Not applicable
(d)   Not applicable
(e)   Not applicable

Instruction.  For computations  regarding  securities which represent a right to
acquire an underlying security, see Rule 13d-3(d)(1) and the note thereto.

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to
Securities of the Issuer

SEE EXHIBIT "1" ATTACHED

The filing person is aware that other unrelated  holders of shares of the issuer
also believe that the issuer should  explore a sale or other  disposition of the
company. In communications with the issuer, the filing person has indicated that
this is the view of other  shareholders.  The filing  person  has no  agreement,
express or implied, formal or informal, with such other shareholders or with any
other unrelated party with respect to shares of the issuer.


Item 7. Material to Be Filed as Exhibits

SEE EXHIBIT "2" ATTACHED

Signature

     After  reasonable  inquiry and to the best of my  knowledge  and belief,  I
certify that the information  set forth in this statement is true,  complete and
correct.

September 30, 2004
Date

By: /s/J. Christopher Donahue
Name/Title:  J. Christopher Donahue, as President of Federated Investors, Inc.

By: /s/John F. Donahue
Name/Title:  John F. Donahue, individually and as Trustee of the Voting
Shares Irrevocable Trust, by J. Christopher Donahue, as attorney-in-fact.

By: /s/Rhodora J. Donahue
Name/Title:  Rhodora J. Donahue, individually and as Trustee of the Voting
Shares Irrevocable Trust, by J. Christopher Donahue, as attorney-in-fact.

By: /s/J. Christopher Donahue
Name/Title:  J. Christopher Donahue, individually and as Trustee of the Voting
Shares Irrevocable Trust, by J. Christopher Donahue, as attorney-in-fact.

     The original  statement  shall be signed by each person on whose behalf the
statement is filed or his authorized representative.  If the statement is signed
on behalf of a person by his authorized  representative (other than an executive
officer  or  general   partner  of  the   filing   person),   evidence   of  the
representative's  authority to sign on behalf of such person shall be filed with
the  statement:  provided,  however,  that a power of attorney  for this purpose
which is already on file with the Commission may be  incorporated  by reference.
The name and any title of each person who signs the statement  shall be typed or
printed beneath his signature.

Attention:  Intentional  misstatements  or omissions of fact constitute  Federal
criminal violations (See 18 U.S.C. 1001)

                                   EXHIBIT "1"

                            ITEM 6 CLASSIFICATION OF
                                REPORTING PERSONS
              Identity and Classification of Each Reporting Person



                                                

IDENTITY                                           CLASSIFICATION UNDER ITEM 6

Federated Equity Funds                             (d) Investment company registered under
                                                   Section 8 of the Investment Company Act of
                                                   1940 (15 U.S.C. 80a-8).

Federated Insurance Series                         (d) Investment company registered under
                                                   Section 8 of the Investment Company Act of
                                                   1940 (15 U.S.C. 80a-8).

Federated Equity Management Company                (e) Investment Adviser registered
        of Pennsylvania                            under section 203 of the
                                                   Investment Advisers Act of 1940

Federated Global Investment                        (e) Investment Adviser registered
        Management Corp.                           under section 203 of the Investment
                                                   Advisers Act of 1940

Federated Investors, Inc.                          (g) Parent Holding Company, in accordance with Section
                                                   240.13d-1(b)(ii)(G)

FII Holdings, Inc.                                 (g) Parent Holding Company, in accordance with Section
                                                   240.13d-1(b)(ii)(G)

Voting Shares Irrevocable Trust                    (g) Parent Holding Company, in accordance with Section
                                                   240.13d-1(b)(ii)(G)

John F. Donahue                                    (g) Parent Holding Company, in accordance with Section
                                                   240.13d-1(b)(ii)(G)

Rhodora J. Donahue                                 (g) Parent Holding Company, in accordance with Section
                                                   240.13d-1(b)(ii)(G)

J. Christopher Donahue                             (g) Parent Holding Company, in accordance with Section
                                                   240.13d-1(b)(ii)(G)



Federated Investors,  Inc. (the "Parent") is filing this Schedule 13D because it
is the  parent  holding  company  of  Federated  Equity  Management  Company  of
Pennsylvania and Federated Global  Investment  Management Corp. (the "Investment
Advisers"),  which act as investment advisers to registered investment companies
and separate accounts that own shares of common stock in NMT Medical,  Inc. (the
"Reported Securities'). The Investment Advisers are wholly owned subsidiaries of
FII Holdings,  Inc.,  which is wholly owned  subsidiary of Federated  Investors,
Inc., the Parent.  All of the Parent's  outstanding  voting stock is held in the
Voting Shares Irrevocable Trust (the "Trust") for which John F. Donahue, Rhodora
J.  Donahue  and J.  Christopher  Donahue  act as  trustees  (collectively,  the
"Trustees"). The Trustees have joined in filing this Schedule 13D because of the
collective voting control that they exercise over the Parent. In accordance with
Rule 13d-4 under the Securities Act of 1934, as amended,  the Parent, the Trust,
and each of the Trustees  declare that this statement should not be construed as
an admission that they are the beneficial owners of the Reported Securities, and
the Parent, the Trust, and each of the Trustees  expressly  disclaim  beneficial
ownership of the Reported Securities

                                   EXHIBIT "2"

                          AGREEMENT FOR JOINT FILING OF

                                  SCHEDULE 13D

     The  following  parties  hereby  agree to file  jointly  the  statement  on
Schedule  13D to which this  Agreement is attached  and any  amendments  thereto
which may be deemed necessary  pursuant to Regulation 13D-G under the Securities
Exchange Act of 1934:

Federated  Investors,  Inc. as parent holding company of the investment advisers
to registered investment companies that beneficially own the securities.

Voting Shares Irrevocable Trust, as holder of all the voting shares of
Federated Investors, Inc.

John F. Donahue, individually and as Trustee

Rhodora J. Donahue, individually and as Trustee

J. Christopher Donahue, individually and as Trustee

     It is understood  and agreed that each of the parties hereto is responsible
for the timely filing of such statement and any amendments thereto,  and for the
completeness  and accuracy of the  information  concerning  such party contained
therein,  but such party is not responsible for the  completeness or accuracy of
information  concerning  the other parties unless such party knows or has reason
to believe that such information is incomplete or inaccurate.

     It is understood and agreed that the joint filing of Schedule 13D shall not
be construed as an admission that the reporting  persons named herein constitute
a group for purposes of Regulation 13D-G of the Securities Exchange Act of 1934,
nor is a joint venture for purposes of the Investment Company Act of 1940.

Date:   September 30, 2004

By:     /s/J. Christopher Donahue
Name/Title: J. Christopher Donahue, as President of Federated Investors, Inc.

By:     /s/ J. Christopher Donahue
Name/Title:    John F. Donahue, individually and as Trustee of Voting Shares
Irrevocable Trust, by J. Christopher Donahue, as attorney-in-fact.

By:     /s/    Rhodora J. Donahue
Name/Title:    Rhodora J. Donahue, individually and as Trustee as Voting Shares
Irrevocable Trust, by J. Christopher Donahue, as attorney-in-fact.

By:     /s/    J. Christopher Donahue
Name/Title:    J. Christopher Donahue, individually and as Trustee of Voting
Shares Irrevocable Trust

The number of shares indicated represent shares beneficially owned by registered
investment  companies and separate accounts advised by subsidiaries of Federated
Investors,  Inc. that have been  delegated the power to direct  investments  and
power to vote the securities by the registered  investment  companies'  board of
trustees or  directors  and by the  separate  accounts'  principals.  All of the
voting  securities  of Federated  Investors,  Inc. are held in the Voting Shares
Irrevocable Trust ("Trust"),  the trustees of which are John F. Donahue, Rhodora
J. Donahue,  and J. Christopher  Donahue  ("Trustees').  In accordance with Rule
13d-4  under the 1934 Act,  the  Trust,  Trustees,  and parent  holding  company
declare  that  the  filing  of this  statement  should  not be  construed  as an
admission that any of the investment  advisers,  parent holding company,  Trust,
and Trustees are  beneficial  owners (for the purposes of Sections  13(d) and/or
13(g)  of the  Act) of any  securities  covered  by  this  statement,  and  such
advisers,  parent holding company,  Trust, and Trustees  expressly disclaim that
they are the beneficial owners such securities.

                                POWER OF ATTORNEY

     Each person who signature appears below hereby  constitutes and appoints J.
Christopher Donahue their true and lawful  attorney-in-fact and agent, with full
power of substitution and  resubstitution for them and in their names, place and
stead,  in any and all  capacities,  to sign any and all  Schedule  13Ds  and/or
Schedule 13Gs, and any amendments  thereto,  to be filed with the Securities and
Exchange  commission pursuant to Regulation 13D-G of the Securities Exchange Act
of 1934,  as  amended,  by means of the  Securities  and  Exchange  Commission's
electronic  disclosure  system  known as EDGAR;  and to file the same,  with all
exhibits  thereto  and  other  documents  in  connection  therewith,   with  the
Securities  and Exchange  Commission,  granting unto said  attorney-in-fact  and
agent, full power and authority to sign and perform each and every act and thing
requisite  and  necessary to be done in  connection  therewith,  as fully to all
intents  and  purposes  as each of them  might  or could  do in  person,  hereby
ratifying and confirming all that said  attorney-in-fact  and agent, or their or
his  substitute  or  substitutes,  may lawfully do or cause to be done by virtue
thereof.


SIGNATURES                            TITLE OR CAPACITY

/s/John F. Donahue                    Individually and as Trustee of
John F. Donahue                       the Voting Shares Irrevocable Trust

/s/Rhodora J. Donahue                 Individually and as Trustee of
Rhodora J. Donahue                    the Voting Shares Irrevocable Trust


Sworn to and subscribed before me this 23rd day of September, 2004.

/s/Madaline P. Kelly
Notary Public
My Commission Expires: February 22, 2008